Prodia Officially Launches Prodia Women’s Health Center

In Prodia Women' s Health Center (PWHC) every woman can access a Health Service based on her needs.

PT Prodia Widyahusada Tbk (Prodia) Managing Director Dewi Muliaty (middle), together with PWHC Doctor in Charge DR. dr. Raditya Wratsangka, Sp.OG (K) [left], and PWHC Project Manager Rini Budiyati (right), officially launched Prodia Women' s Health Center.

JAKARTA, 8 March 2017 - PT Prodia Widyahusada Tbk (PRDA), the pioneer and leader of clinical laboratory in Indonesia, today, on the International Women' s Day, makes another breakthrough by introducing and inaugurating the first special health service for women in Indonesia with women-wellness basis, namely Prodia Women' s Health Center (PWHC). This health clinic located in Wolter Monginsidi, Jakarta Selatan, will provide comprehensive health services with a special design supported by the state-of-the-art equipment of diagnostic technology.

Prodia Managing Dirctor Dewi Muliaty stated that the establishment of this women' s health service center is a part of Prodia' s strategy to optimize its performance in the ever-growing health service market in Indonesia. Through PWHC, Prodia expects that Indonesian women will get the best health service with high level of convenience based on their respective needs and lifestyles.

"We are glad that finally Prodia can introduce the first women wellness-based health service equipped with the most up-to-date technology. Through PWHC we are about to present the new experience of health diagnosis for women to realize the more healthy Indonesia," said Dewi after officially launching PWHC in Jakarta on Wednesday (8/3).

Dewi added that PWHC was founded because women deserve special treatments. Moreover, Indonesia' s female population is nearly a half of its total population of 254.9 million people based on the 2015 data of Statistics Indonesia (BPS).

"The middle-class women in Indonesia keep growing and most of them take a part in the decision-making within the families. This encourages Prodia to give its best services for Indonesian women," she added.

Prodia Managing Director Dewi Muliaty (middle), in the press conference of Prodia Women' s Health Center

Prodia Marketing Director, Indriyanti Rafi Sukmawati explained that in PWHC the female customers have a lot of choices for the preventive services, starting from primary prevention, such as workshop/education further preventive vaccination/immunization (secondary prevention), such as medical check-up, complete laboratory test, and pap smear test Diagnostic Center consisting of Ob/Gyn USG, Colposcopy, LLETZ, Hysterosalpingography, Breast USG, X-ray (Rontgen), and Electrocardiography as well as doctor' s consultation, either with general practitioners or specialists and sub-specialists. In the near future, PWHC will also provide Hysteroscopy and Mammography services. According to "Well-Woman Annual Health Assessment Recommendations" (ACOG, 2012), the stages of patients' age are divided into 13-18 years old, 19-39 years old, 40-64 years old, and above 65 years old. Every stage of age entails different needs and PHWC can provide the services suitable for each stage.

"We established PWHC by reflecting on women' s character and touch. The interior design, service area, medical test and the specialists in charge are also dedicated to meet the women' s needs," Indriyanti added.

Prodia' s Network Expansion Plan

As the pioneer of clinical laboratory in Indonesia, said Dewi, Prodia will continuously improve its services in Indonesia, not only in the scope of clinical laboratory, but also to expand its network towards special clinic.

A patient having the check-up accompanied by (left-right) Prodia Managing Director Dewi Muliaty, PWHC Project Manager Rini Budiyati, dr. Soraya, and PWHC Doctor in Charge of PWHC DR. dr. Raditya Wratsangka, Sp.OG (K) [left]

Up to the end of December 2016, Prodia has had 259 outlets consisting of 129 clinical laboratory (4 of which are with additional permits and PHC clinic services), 1 stand-alone Prodia Health Care (PHC clinic), 2 special clinics, 9 hospital laboratories, and 118 Point of Care (POC) Service at the doctors clinics across 31 provinces and 106 cities in Indonesia.

According to Dewi, along with the middle-class population growth and urbanization, the need for health in urban areas will always increase. Frost & Sullivan, an independent market research institution, projects Indonesia' s healthcare budget to reach US$50.4 billion in 2020. Thus, Prodia will always optimize this potential.

"As a company with a 43-year-plus track record, Prodia will be present in all provinces and become the health solution for Indonesian people. We are optimistic that with a comprehensive service standard and the support of the most recent equipment of diagnosis technology, Prodia will generate a sustainable business growth in the future," stated Dewi.

---THE END---

About PT Prodia Widyahusada Tbk

Prodia Clinical Laboratory was initially established in Solo on 7 May 1973 by a group of idealist pharmacists. From the very first, Drs. Andi Wijaya, MBA along with the other founders have been committed to present the best check-up result with wholehearted services. That commitment has led Prodia to be the best and the biggest clinical laboratory in Indonesia today and the National Referral Center with the vision to be the Center of Excellence and the trusted health service to support the next generation medicine.

Since 2009, Prodia has set the theme 'Love for Quality' to inspire all employees of Prodia in providing services for the customers. 'Love for Quality' is the actualization of efforts for the endless improvement, which is based on love in order to provide quality service since Prodia believes that love and you, the loyal customers, are one inseparable unity.

As the market leader, since 2012 Prodia has been the only laboratory and clinic in Indonesia accredited by the College of American Pathologists (CAP). It implies that the quality of the test result from Prodia' s laboratory is equal to those of international laboratories.

On 7 December 2016, the Indonesia Stock Exchange officially listed the initial public offering of Prodia as the 15th issuer in 2016, with the ticker symbol "PRDA." In that corporate action, Prodia offered 187.5 million shares. Accordingly, the fund raised from the company' s initial public offering is Rp1.218 trillion.

For further information, please contact:

Marina Eka Amalia

Legal Head & Corporate Secretary

PT Prodia Widyahusada Tbk

Email: corporate.secretary@prodia.co.id

Jl. Kramat Raya 150, Jakarta 10430

Fax: (+6221) 314 4181, 392 1247

Berliana Elisabeth Simarmata

PT Sembilan Komunikasi Utama (9Comm)

for PT Prodia Widyahusada Tbk

Email: berliana@ninecomm.co.id

+62812 8217 0549